Skip to main content
. 2019 May 6;41(1):370–376. doi: 10.1080/0886022X.2019.1605295

Table 3.

Clinical and pathological manifestations of IgAN patients grouped according to HECW1 levels.

Variables Low HECW1 Group (≤0.58, n = 20) High HECW1 Group (>0.58, n = 20) p value
Age (mean ± SD, year) 35.8 ± 9.76 38.11 ± 11.65 .88
Gender (M/F, %) 17 (60)/18 (40) 27 (50)/20 (50) .50
SBP (mmHg, mean ± SD) 126 ± 13 125 ± 11 .67
Proteinuria (g/24h, median, IQR) 1.12 (0.45–3.80) 1.25 (0.43–3.54) .45
eGFR (mL/min/1.73 m2, mean ± SD) 83.88 ± 30.40 80.21 ± 22.78 .83
Uric acid (μmol/L, mean ± SD) 411.23 ± 109.14 398.21 ± 80.44 .54
Plasma IgA1 (μg/mL, median, IQR) 1728 (980–2558) 1215 (765–1583) .04
Oxford classification (%)      
 M score (M0/M1) 2 (10)/18 (90) 4 (20)/16 (80) .38
 E score (E0/E1) 15 (75)/5 (25) 13 (65)/7 (35) .49
 S score (S0/S1) 9 (45)/11 (55) 13 (65)/7 (35) .20
 T score (T0/T1/T2) 10 (50)/8 (40)/2 (10) 8 (40)/10 (50)/2 (10) .80
 C score (C0/C1/C2) 3 (15)/14 (70)/3 (15) 7 (10)/8 (75)/5 (15) .15

eGFR: estimated glomerular filtration rate; IQR: interquartile range; SBP: systolic blood pressure; SD: standard deviation.